Literature DB >> 1549004

Prediction of claudication pain from clinical measurements obtained at rest.

A W Gardner1, J S Skinner, B W Cantwell, L K Smith.   

Abstract

The ability to predict claudication pain during single-stage (S) and progressive (P) treadmill protocols from clinical measurements obtained at rest was examined. Peripheral hemodynamic measurements from the more severely diseased lower limb and medical history data were obtained from 56 claudicant patients during supine rest immediately preceding S (1.5 mph and 7.5% grade) and P (2 mph, 0% grade with 2% increase every 2 min) treadmill protocols. Distance walked to onset of claudication pain (CPD) and to maximal pain (MPD) during both protocols were recorded. The claudication distances during the S protocol were not correlated with either the peripheral hemodynamic or medical history variables. In contrast, CPD and MPD during the P protocol were predicted (P less than 0.05) by ankle/brachial systolic blood pressure index (ABI) (quadratic relationship), laterality of claudication pain (1 = unilateral, 2 = bilateral), and gender (1 = female, 2 = male) from the following regression equations: CDP (m) = 159.9 - (321.8 x ABI) + (445.6 x ABI2) - (93.5 x laterality) + (99.0 x gender), R = 0.74, R2 = 0.55, adjusted R2 = 0.53, SEE = 110.5, P less than 0.0001; and MPD (m) = 83.1 + (195.0 x ABI) + (174.0 x ABI2) - (76.4 x laterality) + (114.2 x gender), R = 0.76, R2 = 0.58, adjusted R2 = 0.55, SEE = 138.3, P less than 0.0001. It is concluded that the regression equations for the prediction of CPD and MPD may be used to quickly estimate the functional severity of peripheral vascular occlusive disease in clinical settings where treadmill testing is not feasible or is impractical.

Entities:  

Mesh:

Year:  1992        PMID: 1549004

Source DB:  PubMed          Journal:  Med Sci Sports Exerc        ISSN: 0195-9131            Impact factor:   5.411


  19 in total

1.  Relationship between leg muscle capillary density and peak hyperemic blood flow with endurance capacity in peripheral artery disease.

Authors:  Jennifer L Robbins; W Schuyler Jones; Brian D Duscha; Jason D Allen; William E Kraus; Judith G Regensteiner; William R Hiatt; Brian H Annex
Journal:  J Appl Physiol (1985)       Date:  2011-04-21

2.  Percutaneous intervention in peripheral artery disease improves calf muscle phosphocreatine recovery kinetics: a pilot study.

Authors:  Amy M West; Justin D Anderson; Frederick H Epstein; Craig H Meyer; Klaus D Hagspiel; Stuart S Berr; Nancy L Harthun; Arthur L Weltman; Brian H Annex; Christopher M Kramer
Journal:  Vasc Med       Date:  2012-02       Impact factor: 3.239

3.  A pooled analysis of the durability and predictors of treatment response of cilostazol in patients with intermittent claudication.

Authors:  Reena L Pande; William R Hiatt; Peter Zhang; Norbert Hittel; Mark A Creager
Journal:  Vasc Med       Date:  2010-04-12       Impact factor: 3.239

4.  Angiogenesis in skeletal muscle precede improvements in peak oxygen uptake in peripheral artery disease patients.

Authors:  Brian D Duscha; Jennifer L Robbins; William S Jones; William E Kraus; R John Lye; John M Sanders; Jason D Allen; Judith G Regensteiner; William R Hiatt; Brian H Annex
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-11       Impact factor: 8.311

5.  Blood pressure and leg deoxygenation are exaggerated during treadmill walking in patients with peripheral artery disease.

Authors:  Amanda J Miller; J Carter Luck; Danielle Jin-Kwang Kim; Urs A Leuenberger; David N Proctor; Lawrence I Sinoway; Matthew D Muller
Journal:  J Appl Physiol (1985)       Date:  2017-08-17

6.  Arterial spin labeling MR imaging reproducibly measures peak-exercise calf muscle perfusion: a study in patients with peripheral arterial disease and healthy volunteers.

Authors:  Amy W Pollak; Craig H Meyer; Frederick H Epstein; Ronny S Jiji; Jennifer R Hunter; Joseph M Dimaria; John M Christopher; Christopher M Kramer
Journal:  JACC Cardiovasc Imaging       Date:  2012-12

7.  Abnormal myofiber morphology and limb dysfunction in claudication.

Authors:  Panagiotis Koutakis; Sara A Myers; Kim Cluff; Duy M Ha; Gleb Haynatzki; Rodney D McComb; Koji Uchida; Dimitrios Miserlis; Evlampia Papoutsi; Jason M Johanning; George P Casale; Iraklis I Pipinos
Journal:  J Surg Res       Date:  2015-02-13       Impact factor: 2.192

8.  Diffuse optical characterization of an exercising patient group with peripheral artery disease.

Authors:  Rickson C Mesquita; Mary Putt; Malavika Chandra; Guoqiang Yu; Xiaoman Xing; Sung Wan Han; Gwen Lech; Yu Shang; Turgut Durduran; Chao Zhou; Arjun G Yodh; Emile R Mohler
Journal:  J Biomed Opt       Date:  2013-05       Impact factor: 3.170

9.  Calf muscle hemoglobin oxygen saturation characteristics and exercise performance in patients with intermittent claudication.

Authors:  Andrew W Gardner; Donald E Parker; Nykita Webb; Polly S Montgomery; Kristy J Scott; Steve M Blevins
Journal:  J Vasc Surg       Date:  2008-06-24       Impact factor: 4.268

10.  Neuromuscular stimulation ameliorates ischemia-induced walking impairment in the rat claudication model.

Authors:  Momoko Shiragaki-Ogitani; Keita Kono; Futoshi Nara; Atsushi Aoyagi
Journal:  J Physiol Sci       Date:  2019-08-06       Impact factor: 2.781

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.